David H Howard
Overview
Explore the profile of David H Howard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
134
Citations
1894
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tangka F, Kenney K, Miller J, Howard D
Cancer Causes Control
. 2025 Jan;
PMID: 39779647
Purpose: The National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides access to timely breast and cervical cancer screening and diagnostic services to women who have low incomes and...
2.
Howard D, Dickert N, Merchant F
J Cardiovasc Electrophysiol
. 2024 Aug;
35(10):2058-2061.
PMID: 39121462
Introduction: The Centers for Medicare & Medicaid Services (CMS) required a shared decision-making (SDM) interaction, with an "independent" physician, before left atrial appendage closure (LAAC). The purpose of this study...
3.
Filson C, Richards T, Ekwueme D, Howard D
Urol Pract
. 2024 Apr;
11(3):489-497.
PMID: 38640419
Introduction: Therapeutic options for men with metastatic prostate cancer have increased in the past decade. We studied recent treatment patterns for men with metastatic prostate cancer and how treatment patterns...
4.
5.
Zheng Z, Shi K, Kamal A, Howard D, Horny M, Richards T, et al.
J Cancer Surviv
. 2023 Dec;
PMID: 38102521
Background: Few studies have comprehensively compared health-related quality of life (HRQoL) between metastatic prostate cancer survivors, survivors with non-metastatic disease, and men without a cancer history. Methods: We used the...
6.
Peters M, Eckel A, Seguin C, Davidi B, Howard D, Knudsen A, et al.
JCO Oncol Pract
. 2023 Dec;
20(2):278-290.
PMID: 38086003
Purpose: We evaluated the potential cost-effectiveness of combined magnetic resonance imaging (MRI) and endoscopic ultrasound (EUS) screening for pancreatic ductal adenocarcinoma (PDAC) among populations at high risk for the disease....
7.
Howard D, David G
Health Serv Res
. 2023 Oct;
59(2):e14254.
PMID: 37875259
Objective: In light of Department of Justice investigations of for-profit chains for over-admitting patients, we sought to evaluate whether for-profit hospitals are more likely to admit patients from the emergency...
8.
Horny M, Yabroff K, Filson C, Zheng Z, Ekwueme D, Richards T, et al.
Cancer
. 2023 Jun;
129(20):3252-3262.
PMID: 37329254
Background: Recent advancements in the clinical management of metastatic prostate cancer include several costly therapies and diagnostic tests. The objective of this study was to provide updated information on the...
9.
Leung A, Patil D, Howard D, Filson C
Urol Pract
. 2023 Jun;
7(2):138-144.
PMID: 37317428
Introduction: Use of magnetic resonance imaging for prostate biopsies has increased and more biopsies are performed in nonoffice based settings. These changes will likely impact payments related to prostate biopsies....
10.
Olsen T, Filson C, Richards T, Ekwueme D, Howard D
Urol Pract
. 2023 Apr;
10(1):41-47.
PMID: 37103444
Introduction: We sought to estimate per patient and annual aggregate health care costs related to metastatic prostate cancer. Methods: Using the Surveillance, Epidemiology, and End Results-Medicare database, we identified fee-for-service...